1 (888) 801-4801
Bard - 5954124 - BARD VENTRALIGHT ST MESH 12" X 14" RECTANGLE
Prescription or Medical/Professional/ DME License Required. Upload or Send via e-mail.
Uncoated medium weight monofilament polypropylene mesh on the anterior side with an absorbable hydrogel barrier based on Sepra Technology on the posterior side for laparoscopic ventral hernia repair.
Healthcare Professional Downloads:
* Preclinical data on file at C. R. Bard. Results may not correlate to performance in humans.
** Based on a preclinical study of a composite polypropylene/ePTFE hernia repair mesh.
INDICATIONS
Ventralight ST Mesh is indicated for use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias.
CONTRAINDICATIONS
- Do not use the Ventralight ST in infants or children whereby future growth will be compromised by use of such material.
- Do not use Ventralight ST Mesh for the reconstruction of cardiovascular defects.
- Literature reports there may be a possibility for adhesion formation when the polypropylene is placed in direct contact with the bowel or viscera.
WARNINGS
- Ensure proper orientation; the coated side of the prosthesis should be oriented against the bowel or sensitive organs. Do not place the polypropylene side against the bowel. There may be a possibility for adhesion formation when the polypropylene side is placed in direct contact with the bowel or viscera.
- If an infection develops, treat the infection aggressively. Consideration should be given regarding the need to remove the prosthesis. An unresolved infection may require removal of the prosthesis. Possible complications include seroma, adhesions, hematomas, inflammation, extrusion, fistula formation and recurrence of the hernia or soft tissue defect.
ADVERSE REACTIONS
Possible complications include seroma, adhesions, hematomas, inflammation, extrusion, fistula formation, infection, allergic reaction, and recurrence of the hernia or soft tissue defect.
Please consult package insert for more detailed safety information and instructions for use.
DAV/VLST/0917/0046(1)
Effective:
Minimal contraction shown in preclinical testing compared to a leading macroporous absorbable barrier mesh
At 4 weeks, Ventralight ST Mesh demonstrated 42% less area mesh contracture than a competitive macroporous absorbable barrier mesh. Results were statistically significant.*
Bard Ventralight St Mesh 12 X 14 Rectangle
Manufacturer | Bard |
---|---|
Code | 5954124 |
Sold By | Each |
HCPCS | - |
UPC | - |
GTIN | - |
Warehouse | MultiWH |
WHSXX | GES |